Identification of high-affinity anti-CD16A allotype-independent human antibody domains
- 1 October 2016
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 101 (2) , 281-289
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program
- National Cancer Institute
- National Institutes of Health
- Stand Up To Cancer (SU2C-AACR-DT113)
This publication has 34 references indexed in Scilit:
- Soluble Monomeric IgG1 FcJournal of Biological Chemistry, 2012
- Combination of the CHARMM27 force field with united‐atom lipid force fieldsJournal of Computational Chemistry, 2010
- Natural killer cells in human autoimmune diseasesImmunology, 2010
- Isolation and characterization of anti-Fc RIII (CD16) llama single-domain antibodies that activate natural killer cellsProtein Engineering, Design and Selection, 2007
- Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s MacroglobulinemiaJournal of Clinical Oncology, 2005
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002
- Clinical Development of 2B1, a Bispecific Murine Monoclonal Antibody Targeting c-erbB-2 and FcγRIIIJournal of Hematotherapy, 1995
- Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.Journal of Experimental Medicine, 1989
- The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuriaNature, 1988
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985